BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20439539)

  • 1. Invariant NKT cells limit activation of autoreactive CD1d-positive B cells.
    Wermeling F; Lind SM; Jordö ED; Cardell SL; Karlsson MC
    J Exp Med; 2010 May; 207(5):943-52. PubMed ID: 20439539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invariant NKT cells inhibit autoreactive B cells in a contact- and CD1d-dependent manner.
    Yang JQ; Wen X; Kim PJ; Singh RR
    J Immunol; 2011 Feb; 186(3):1512-20. PubMed ID: 21209282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invariant natural killer T cells in lupus patients promote IgG and IgG autoantibody production.
    Shen L; Zhang H; Caimol M; Benike CJ; Chakravarty EF; Strober S; Engleman EG
    Eur J Immunol; 2015 Feb; 45(2):612-23. PubMed ID: 25352488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR9-induced miR-155 and Ets-1 decrease expression of CD1d on B cells in SLE.
    Liu F; Fan H; Ren D; Dong G; Hu E; Ji J; Hou Y
    Eur J Immunol; 2015 Jul; 45(7):1934-45. PubMed ID: 25929465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.
    Guggino G; Ciccia F; Raimondo S; Giardina G; Alessandro R; Dieli F; Sireci G; Triolo G
    Clin Exp Rheumatol; 2016; 34(1):25-31. PubMed ID: 26633038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells.
    Bosma A; Abdel-Gadir A; Isenberg DA; Jury EC; Mauri C
    Immunity; 2012 Mar; 36(3):477-90. PubMed ID: 22406267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of iNKT cells in the immunopathology of systemic lupus erythematosus.
    Gabriel L; Morley BJ; Rogers NJ
    Ann N Y Acad Sci; 2009 Sep; 1173():435-41. PubMed ID: 19758183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role and regulation of CD1d in normal and pathological B cells.
    Chaudhry MS; Karadimitris A
    J Immunol; 2014 Nov; 193(10):4761-8. PubMed ID: 25381357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction.
    Gentilini MV; Pérez ME; Fernández PM; Fainboim L; Arana E
    Cancer Immunol Immunother; 2016 May; 65(5):551-62. PubMed ID: 26969612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
    Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
    Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment.
    Miellot-Gafsou A; Biton J; Bourgeois E; Herbelin A; Boissier MC; Bessis N
    Immunology; 2010 Jun; 130(2):296-306. PubMed ID: 20113367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of marginal zone B lymphocytes in invariant NKT cell activation.
    Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
    J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Invariant NKT in Autoimmune Liver Disease: Can Vitamin D Act as an Immunomodulator?
    Smyk DS; Mavropoulos A; Mieli-Vergani G; Vergani D; Lenzi M; Bogdanos DP
    Can J Gastroenterol Hepatol; 2018; 2018():8197937. PubMed ID: 30046564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased CD1d level is associated with CD86 over-expression in B cells from systemic lupus erythematosus.
    Liu F; Ji J; Li X; Li X; Xu J; Yue H; Zhao S; Fan H; Hou Y
    Acta Biochim Biophys Sin (Shanghai); 2017 Apr; 49(4):328-337. PubMed ID: 28338767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JNK2 modulates the CD1d-dependent and -independent activation of iNKT cells.
    Liu J; Gallo RM; Khan MA; Iyer AK; Kratzke IM; Brutkiewicz RR
    Eur J Immunol; 2019 Feb; 49(2):255-265. PubMed ID: 30467836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD1d-unrestricted NKT cells are endowed with a hybrid function far superior than that of iNKT cells.
    Farr AR; Wu W; Choi B; Cavalcoli JD; Laouar Y
    Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12841-6. PubMed ID: 25143585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of invariant natural killer T (iNKT) cells in systemic lupus erythematosus.
    Godó M; Sessler T; Hamar P
    Curr Med Chem; 2008; 15(18):1778-87. PubMed ID: 18691038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulatory function of invariant natural killer T cells in systemic lupus erythematosus.
    Chuang YP; Wang CH; Wang NC; Chang DM; Sytwu HK
    Clin Dev Immunol; 2012; 2012():478429. PubMed ID: 22761630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD1d-Restricted pathways in hepatocytes control local natural killer T cell homeostasis and hepatic inflammation.
    Zeissig S; Peuker K; Iyer S; Gensollen T; Dougan SK; Olszak T; Kaser A; Blumberg RS
    Proc Natl Acad Sci U S A; 2017 Sep; 114(39):10449-10454. PubMed ID: 28893990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
    Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
    Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.